Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 187 entries
Sorted by: Best Match Show Resources per page
The Role of NG2 Proteoglycan in Glioma.

Translational oncology

Yadavilli S, Hwang EI, Packer RJ, Nazarian J.
PMID: 26947882
Transl Oncol. 2016 Feb;9(1):57-63. doi: 10.1016/j.tranon.2015.12.005.

Neuron glia antigen-2 ((NG2), also known as chondroitin sulphate proteoglycan 4, or melanoma-associated chondroitin sulfate proteoglycan) is a type-1 membrane protein expressed by many central nervous system (CNS) cells during development and differentiation and plays a critical role in...

Cite
Yadavilli S, Hwang EI, Packer RJ, et al. The Role of NG2 Proteoglycan in Glioma. Transl Oncol. 2016;9(1):57-63doi: 10.1016/j.tranon.2015.12.005.
Yadavilli, S., Hwang, E. I., Packer, R. J., & Nazarian, J. (2016). The Role of NG2 Proteoglycan in Glioma. Translational oncology, 9(1), 57-63. https://doi.org/10.1016/j.tranon.2015.12.005
Yadavilli, Sridevi, et al. "The Role of NG2 Proteoglycan in Glioma." Translational oncology vol. 9,1 (2016): 57-63. doi: https://doi.org/10.1016/j.tranon.2015.12.005
Yadavilli S, Hwang EI, Packer RJ, Nazarian J. The Role of NG2 Proteoglycan in Glioma. Transl Oncol. 2016 Feb;9(1):57-63. doi: 10.1016/j.tranon.2015.12.005. PMID: 26947882; PMCID: PMC4800061.
Copy Download .nbib Format: NLM
Facilitation of transvenous lead extraction using site-specific delivery of electrosurgical energy.

International journal of cardiology. Heart & vessels

Catanzaro JN, Zviman M, Kolandaivelu A, Nazarian S, Halperin H, Berger RD, Brinker JA, Cheng A.
PMID: 29450175
Int J Cardiol Heart Vessel. 2014 Mar 22;3:75-77. doi: 10.1016/j.ijchv.2014.03.008. eCollection 2014 Jun.

INTRODUCTION: Excimer laser energy is often required to extract chronically indwelling pacemaker and defibrillator leads from the vasculature and myocardium. This technique can be associated with vascular and right ventricular (RV) injuries. We sought to develop a safer, more...

Cite
Catanzaro JN, Zviman M, Kolandaivelu A, et al. Facilitation of transvenous lead extraction using site-specific delivery of electrosurgical energy. Int J Cardiol Heart Vessel. 2014;3:75-77doi: 10.1016/j.ijchv.2014.03.008.
Catanzaro, J. N., Zviman, M., Kolandaivelu, A., Nazarian, S., Halperin, H., Berger, R. D., Brinker, J. A., & Cheng, A. (2014). Facilitation of transvenous lead extraction using site-specific delivery of electrosurgical energy. International journal of cardiology. Heart & vessels, 375-77. https://doi.org/10.1016/j.ijchv.2014.03.008
Catanzaro, John N, et al. "Facilitation of transvenous lead extraction using site-specific delivery of electrosurgical energy." International journal of cardiology. Heart & vessels vol. 3 (2014): 75-77. doi: https://doi.org/10.1016/j.ijchv.2014.03.008
Catanzaro JN, Zviman M, Kolandaivelu A, Nazarian S, Halperin H, Berger RD, Brinker JA, Cheng A. Facilitation of transvenous lead extraction using site-specific delivery of electrosurgical energy. Int J Cardiol Heart Vessel. 2014 Mar 22;3:75-77. doi: 10.1016/j.ijchv.2014.03.008. eCollection 2014 Jun. PMID: 29450175; PMCID: PMC5801438.
Copy Download .nbib Format: NLM
Safety of herbal medicine in treatment of weight loss.

ARYA atherosclerosis

Najafian J, Abdar-Esfahani M, Arab-Momeni M, Akhavan-Tabib A.
PMID: 24963315
ARYA Atheroscler. 2014 Jan;10(1):55-8.

BACKGROUND: Obesity is a common health problem in both developed and developing countries. There are many unconventional therapies, including herbal medicine, to treat this condition. Some people believe that herbal medicines are safe. This case and review is about...

Cite
Najafian J, Abdar-Esfahani M, Arab-Momeni M, et al. Safety of herbal medicine in treatment of weight loss. ARYA Atheroscler. 2014;10(1):55-8
Najafian, J., Abdar-Esfahani, M., Arab-Momeni, M., & Akhavan-Tabib, A. (2014). Safety of herbal medicine in treatment of weight loss. ARYA atherosclerosis, 10(1), 55-8.
Najafian, Jamshid, et al. "Safety of herbal medicine in treatment of weight loss." ARYA atherosclerosis vol. 10,1 (2014): 55-8.
Najafian J, Abdar-Esfahani M, Arab-Momeni M, Akhavan-Tabib A. Safety of herbal medicine in treatment of weight loss. ARYA Atheroscler. 2014 Jan;10(1):55-8. PMID: 24963315; PMCID: PMC4063522.
Copy Download .nbib Format: NLM
Comparing right ventricular function and pulmonary artery pressure before and shortly after hemodialysis in patients with end-stage renal disease.

Advanced biomedical research

Najafian J, Taheri S, Mahaki B, Molavi S, Alami S, Khalesi S, Salehi A.
PMID: 26601085
Adv Biomed Res. 2015 Sep 28;4:197. doi: 10.4103/2277-9175.166133. eCollection 2015.

BACKGROUND: Early screening and diagnosis of right ventricular (RV) dysfunction and pulmonary artery hypertension is vital in patients with end-stage renal disease (ESRD) because of its relation to patients' survival. The present study is aimed to address and compare...

Cite
Najafian J, Taheri S, Mahaki B, et al. Comparing right ventricular function and pulmonary artery pressure before and shortly after hemodialysis in patients with end-stage renal disease. Adv Biomed Res. 2015;4:197doi: 10.4103/2277-9175.166133.
Najafian, J., Taheri, S., Mahaki, B., Molavi, S., Alami, S., Khalesi, S., & Salehi, A. (2015). Comparing right ventricular function and pulmonary artery pressure before and shortly after hemodialysis in patients with end-stage renal disease. Advanced biomedical research, 4197. https://doi.org/10.4103/2277-9175.166133
Najafian, Jamshid, et al. "Comparing right ventricular function and pulmonary artery pressure before and shortly after hemodialysis in patients with end-stage renal disease." Advanced biomedical research vol. 4 (2015): 197. doi: https://doi.org/10.4103/2277-9175.166133
Najafian J, Taheri S, Mahaki B, Molavi S, Alami S, Khalesi S, Salehi A. Comparing right ventricular function and pulmonary artery pressure before and shortly after hemodialysis in patients with end-stage renal disease. Adv Biomed Res. 2015 Sep 28;4:197. doi: 10.4103/2277-9175.166133. eCollection 2015. PMID: 26601085; PMCID: PMC4620613.
Copy Download .nbib Format: NLM
Adjuvant role of Pseudomonas flagellin for Acinetobacter baumannii biofilm associated protein.

World journal of methodology

Sefidi MD, Rasooli I, Owlia P, Talei D, Astaneh SD, Nazarian S.
PMID: 27679782
World J Methodol. 2016 Sep 26;6(3):190-9. doi: 10.5662/wjm.v6.i3.190. eCollection 2016 Sep 26.

AIM: To study immunogenicity of Pseudomonas N terminal flagellin as an adjuvant for Acinetobacter baumannii (A. baumannii) biofilm associated protein (Bap).METHODS: The N terminal flagellin gene was amplified. The pET28a (+) and polymerase chain reaction products were digested with...

Cite
Sefidi MD, Rasooli I, Owlia P, et al. Adjuvant role of Pseudomonas flagellin for Acinetobacter baumannii biofilm associated protein. World J Methodol. 2016;6(3):190-9doi: 10.5662/wjm.v6.i3.190.
Sefidi, M. D., Rasooli, I., Owlia, P., Talei, D., Astaneh, S. D., & Nazarian, S. (2016). Adjuvant role of Pseudomonas flagellin for Acinetobacter baumannii biofilm associated protein. World journal of methodology, 6(3), 190-9. https://doi.org/10.5662/wjm.v6.i3.190
Sefidi, Mozhgan Derakhshan, et al. "Adjuvant role of Pseudomonas flagellin for Acinetobacter baumannii biofilm associated protein." World journal of methodology vol. 6,3 (2016): 190-9. doi: https://doi.org/10.5662/wjm.v6.i3.190
Sefidi MD, Rasooli I, Owlia P, Talei D, Astaneh SD, Nazarian S. Adjuvant role of Pseudomonas flagellin for Acinetobacter baumannii biofilm associated protein. World J Methodol. 2016 Sep 26;6(3):190-9. doi: 10.5662/wjm.v6.i3.190. eCollection 2016 Sep 26. PMID: 27679782; PMCID: PMC5031927.
Copy Download .nbib Format: NLM
Pericardial effusion in celiac disease.

International journal of preventive medicine

Ashrafi F, Darakhshandeh A, Heidarpour M, Tavakoli T, Najafian J.
PMID: 24829721
Int J Prev Med. 2014 Mar;5(3):356-9.

Celiac disease is an autoimmune disorder that affected 1% of all population in United State. Classic manifestations of disease consist of early childhood diarrhea, malabsorption, steatorrhea and growth retardation but disease can affects adult at any age. In adult...

Cite
Ashrafi F, Darakhshandeh A, Heidarpour M, et al. Pericardial effusion in celiac disease. Int J Prev Med. 2014;5(3):356-9
Ashrafi, F., Darakhshandeh, A., Heidarpour, M., Tavakoli, T., & Najafian, J. (2014). Pericardial effusion in celiac disease. International journal of preventive medicine, 5(3), 356-9.
Ashrafi, Farzaneh, et al. "Pericardial effusion in celiac disease." International journal of preventive medicine vol. 5,3 (2014): 356-9.
Ashrafi F, Darakhshandeh A, Heidarpour M, Tavakoli T, Najafian J. Pericardial effusion in celiac disease. Int J Prev Med. 2014 Mar;5(3):356-9. PMID: 24829721; PMCID: PMC4018646.
Copy Download .nbib Format: NLM
Hereditary Hemorrhagic Telangiectasia Presenting as High Output Cardiac Failure during Pregnancy.

Cardiology research and practice

Goussous T, Haynes A, Najarian K, Daccarett M, David S.
PMID: 19946637
Cardiol Res Pract. 2009;2009:437237. doi: 10.4061/2009/437237. Epub 2009 Sep 07.

High-output cardiac failure secondary to hepatic involvement is a rare complication of hereditary hemorrhagic telangiectasia (HHT). Here we report a 43-year-old woman who presented at 29 weeks gestation of her second pregnancy with complications of right-sided heart failure and...

Cite
Goussous T, Haynes A, Najarian K, et al. Hereditary Hemorrhagic Telangiectasia Presenting as High Output Cardiac Failure during Pregnancy. Cardiol Res Pract. 2009;2009:437237doi: 10.4061/2009/437237.
Goussous, T., Haynes, A., Najarian, K., Daccarett, M., & David, S. (2009). Hereditary Hemorrhagic Telangiectasia Presenting as High Output Cardiac Failure during Pregnancy. Cardiology research and practice, 2009437237. https://doi.org/10.4061/2009/437237
Goussous, Tareq, et al. "Hereditary Hemorrhagic Telangiectasia Presenting as High Output Cardiac Failure during Pregnancy." Cardiology research and practice vol. 2009 (2009): 437237. doi: https://doi.org/10.4061/2009/437237
Goussous T, Haynes A, Najarian K, Daccarett M, David S. Hereditary Hemorrhagic Telangiectasia Presenting as High Output Cardiac Failure during Pregnancy. Cardiol Res Pract. 2009;2009:437237. doi: 10.4061/2009/437237. Epub 2009 Sep 07. PMID: 19946637; PMCID: PMC2778442.
Copy Download .nbib Format: NLM
Which neurotransmitters modulate corneal sensitivity?.

Clinical & experimental optometry

O'Leary DJ, Nazarian J, Millodot M.
PMID: 23714129
Clin Exp Optom. 1986 May;69(3):108-11. doi: 10.1111/j.1444-0938.1986.tb06799.x.

Corneal sensitivity was assessed before and after applying atropine (0.5, 0.05, 0.005% w/v), pilocarpine (1.0, 0.1%), eserine (0.1, 0.01%) and potassium chloride (171mM). Atropine (0.5 - 0.005%) significantly depressed corneal sensitivity; parasympathomimetics, taken together, significantly increased sensitivity. Exposure to...

Cite
O'Leary DJ, Nazarian J, Millodot M. Which neurotransmitters modulate corneal sensitivity?. Clin Exp Optom. 1986;69(3):108-11doi: 10.1111/j.1444-0938.1986.tb06799.x.
O'Leary, D. J., Nazarian, J., & Millodot, M. (1986). Which neurotransmitters modulate corneal sensitivity?. Clinical & experimental optometry, 69(3), 108-11. https://doi.org/10.1111/j.1444-0938.1986.tb06799.x
O'Leary, D J, et al. "Which neurotransmitters modulate corneal sensitivity?." Clinical & experimental optometry vol. 69,3 (1986): 108-11. doi: https://doi.org/10.1111/j.1444-0938.1986.tb06799.x
O'Leary DJ, Nazarian J, Millodot M. Which neurotransmitters modulate corneal sensitivity?. Clin Exp Optom. 1986 May;69(3):108-11. doi: 10.1111/j.1444-0938.1986.tb06799.x. PMID: 23714129.
Copy Download .nbib Format: NLM
A signal processing method to explore similarity in protein flexibility.

Advances in bioinformatics

Vasilache S, Mirshahi N, Ji SY, Mottonen J, Jacobs DJ, Najarian K.
PMID: 21197478
Adv Bioinformatics. 2010;454671. doi: 10.1155/2010/454671. Epub 2010 Dec 20.

Understanding mechanisms of protein flexibility is of great importance to structural biology. The ability to detect similarities between proteins and their patterns is vital in discovering new information about unknown protein functions. A Distance Constraint Model (DCM) provides a...

Cite
Vasilache S, Mirshahi N, Ji SY, et al. A signal processing method to explore similarity in protein flexibility. Adv Bioinformatics. 2010;454671doi: 10.1155/2010/454671.
Vasilache, S., Mirshahi, N., Ji, S. Y., Mottonen, J., Jacobs, D. J., & Najarian, K. (2010). A signal processing method to explore similarity in protein flexibility. Advances in bioinformatics, 454671. https://doi.org/10.1155/2010/454671
Vasilache, Simina, et al. "A signal processing method to explore similarity in protein flexibility." Advances in bioinformatics vol. (2010): 454671. doi: https://doi.org/10.1155/2010/454671
Vasilache S, Mirshahi N, Ji SY, Mottonen J, Jacobs DJ, Najarian K. A signal processing method to explore similarity in protein flexibility. Adv Bioinformatics. 2010;454671. doi: 10.1155/2010/454671. Epub 2010 Dec 20. PMID: 21197478; PMCID: PMC3010618.
Copy Download .nbib Format: NLM
Personalized virtual-heart technology for guiding the ablation of infarct-related ventricular tachycardia.

Nature biomedical engineering

Prakosa A, Arevalo HJ, Deng D, Boyle PM, Nikolov PP, Ashikaga H, Blauer JJE, Ghafoori E, Park CJ, Blake RC, Han FT, MacLeod RS, Halperin HR, Callans DJ, Ranjan R, Chrispin J, Nazarian S, Trayanova NA.
PMID: 30847259
Nat Biomed Eng. 2018 Oct;2(10):732-740. doi: 10.1038/s41551-018-0282-2. Epub 2018 Sep 03.

Ventricular tachycardia (VT), which can lead to sudden cardiac death, occurs frequently in patients with myocardial infarction. Catheter-based radiofrequency ablation of cardiac tissue has achieved only modest efficacy, owing to the inaccurate identification of ablation targets by current electrical...

Cite
Prakosa A, Arevalo HJ, Deng D, et al. Personalized virtual-heart technology for guiding the ablation of infarct-related ventricular tachycardia. Nat Biomed Eng. 2018;2(10):732-740doi: 10.1038/s41551-018-0282-2.
Prakosa, A., Arevalo, H. J., Deng, D., Boyle, P. M., Nikolov, P. P., Ashikaga, H., Blauer, J. J. E., Ghafoori, E., Park, C. J., Blake, R. C., Han, F. T., MacLeod, R. S., Halperin, H. R., Callans, D. J., Ranjan, R., Chrispin, J., Nazarian, S., & Trayanova, N. A. (2018). Personalized virtual-heart technology for guiding the ablation of infarct-related ventricular tachycardia. Nature biomedical engineering, 2(10), 732-740. https://doi.org/10.1038/s41551-018-0282-2
Prakosa, Adityo, et al. "Personalized virtual-heart technology for guiding the ablation of infarct-related ventricular tachycardia." Nature biomedical engineering vol. 2,10 (2018): 732-740. doi: https://doi.org/10.1038/s41551-018-0282-2
Prakosa A, Arevalo HJ, Deng D, Boyle PM, Nikolov PP, Ashikaga H, Blauer JJE, Ghafoori E, Park CJ, Blake RC, Han FT, MacLeod RS, Halperin HR, Callans DJ, Ranjan R, Chrispin J, Nazarian S, Trayanova NA. Personalized virtual-heart technology for guiding the ablation of infarct-related ventricular tachycardia. Nat Biomed Eng. 2018 Oct;2(10):732-740. doi: 10.1038/s41551-018-0282-2. Epub 2018 Sep 03. PMID: 30847259; PMCID: PMC6400313.
Copy Download .nbib Format: NLM
Immunogenicity of enterotoxigenic .

Iranian journal of basic medical sciences

Noroozi N, Gargari SLM, Nazarian S, Sarvary S, Adriani RR.
PMID: 29511495
Iran J Basic Med Sci. 2018 Mar;21(3):284-291. doi: 10.22038/ijbms.2018.25886.6371.

OBJECTIVES: Enterotoxigenic MATERIALS AND METHODS: OMVs was purified from bacterial supernatant by ultracentrifugation. OMVs were encapsulated in chitosan nanoparticles prepared by ionic gelation method within a layer of Eudragit L100 for oral delivery. Female BALB/c mice of 9 weeks'...

Cite
Noroozi N, Gargari SLM, Nazarian S, et al. Immunogenicity of enterotoxigenic . Iran J Basic Med Sci. 2018;21(3):284-291doi: 10.22038/ijbms.2018.25886.6371.
Noroozi, N., Gargari, S. L. M., Nazarian, S., Sarvary, S., & Adriani, R. R. (2018). Immunogenicity of enterotoxigenic . Iranian journal of basic medical sciences, 21(3), 284-291. https://doi.org/10.22038/ijbms.2018.25886.6371
Noroozi, Nafiseh, et al. "Immunogenicity of enterotoxigenic ." Iranian journal of basic medical sciences vol. 21,3 (2018): 284-291. doi: https://doi.org/10.22038/ijbms.2018.25886.6371
Noroozi N, Gargari SLM, Nazarian S, Sarvary S, Adriani RR. Immunogenicity of enterotoxigenic . Iran J Basic Med Sci. 2018 Mar;21(3):284-291. doi: 10.22038/ijbms.2018.25886.6371. PMID: 29511495; PMCID: PMC5817172.
Copy Download .nbib Format: NLM
Design and Assessment Methodology for System Resilience Metrics.

Risk analysis : an official publication of the Society for Risk Analysis

Najarian M, Lim GJ.
PMID: 30763465
Risk Anal. 2019 Sep;39(9):1885-1898. doi: 10.1111/risa.13274. Epub 2019 Feb 14.

By providing objective measures, resilience metrics (RMs) help planners, designers, and decisionmakers to have a grasp of the resilience status of a system. Conceptual frameworks establish a sound basis for RM development. However, a significant challenge that has yet...

Cite
Najarian M, Lim GJ. Design and Assessment Methodology for System Resilience Metrics. Risk Anal. 2019;39(9):1885-1898doi: 10.1111/risa.13274.
Najarian, M., & Lim, G. J. (2019). Design and Assessment Methodology for System Resilience Metrics. Risk analysis : an official publication of the Society for Risk Analysis, 39(9), 1885-1898. https://doi.org/10.1111/risa.13274
Najarian, Mohammad, and Lim, Gino J. "Design and Assessment Methodology for System Resilience Metrics." Risk analysis : an official publication of the Society for Risk Analysis vol. 39,9 (2019): 1885-1898. doi: https://doi.org/10.1111/risa.13274
Najarian M, Lim GJ. Design and Assessment Methodology for System Resilience Metrics. Risk Anal. 2019 Sep;39(9):1885-1898. doi: 10.1111/risa.13274. Epub 2019 Feb 14. PMID: 30763465.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 187 entries